GB1507643A - 4-(5-nitro-2-furyl)quinaldinic acid n-oxide and its use in the treatment of bovine mastitis - Google Patents

4-(5-nitro-2-furyl)quinaldinic acid n-oxide and its use in the treatment of bovine mastitis

Info

Publication number
GB1507643A
GB1507643A GB26938/76A GB2693876A GB1507643A GB 1507643 A GB1507643 A GB 1507643A GB 26938/76 A GB26938/76 A GB 26938/76A GB 2693876 A GB2693876 A GB 2693876A GB 1507643 A GB1507643 A GB 1507643A
Authority
GB
United Kingdom
Prior art keywords
oxide
furyl
nitro
treatment
quinaldinic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB26938/76A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abic Ltd
Original Assignee
Abic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abic Ltd filed Critical Abic Ltd
Publication of GB1507643A publication Critical patent/GB1507643A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB26938/76A 1975-07-03 1976-06-29 4-(5-nitro-2-furyl)quinaldinic acid n-oxide and its use in the treatment of bovine mastitis Expired GB1507643A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL47633A IL47633A (en) 1975-07-03 1975-07-03 Compositions for the treatment of bovine mastitis containing 4-c5-nitro-furyl)-quinaldinic acid n-oxide

Publications (1)

Publication Number Publication Date
GB1507643A true GB1507643A (en) 1978-04-19

Family

ID=11048319

Family Applications (1)

Application Number Title Priority Date Filing Date
GB26938/76A Expired GB1507643A (en) 1975-07-03 1976-06-29 4-(5-nitro-2-furyl)quinaldinic acid n-oxide and its use in the treatment of bovine mastitis

Country Status (20)

Country Link
US (1) US4070469A ( )
JP (1) JPS527971A ( )
AT (1) AT346119B ( )
AU (1) AU510163B2 ( )
BE (1) BE843642A ( )
CH (1) CH601291A5 ( )
DE (1) DE2612250C3 ( )
DK (1) DK298576A ( )
ES (1) ES449874A1 ( )
FI (1) FI761885A ( )
FR (1) FR2315931A1 ( )
GB (1) GB1507643A ( )
IE (1) IE43251B1 ( )
IL (1) IL47633A ( )
IT (1) IT1063791B ( )
LU (1) LU75285A1 ( )
NL (1) NL7607231A ( )
NZ (1) NZ181336A ( )
SE (1) SE7607630L ( )
ZA (1) ZA763747B ( )

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4401666A (en) * 1982-02-01 1983-08-30 Olin Corporation Use of metallic salts of pyridine-2-thione-N-oxide to treat or prevent bovine mastitis
US5101770A (en) * 1990-11-05 1992-04-07 Stevenson Dale V Post-milking and pre-milking udder care
GB9819382D0 (en) * 1998-09-04 1998-10-28 Cerebrus Ltd Chemical compounds I
US20040033938A1 (en) * 2000-09-12 2004-02-19 Britten Nancy J. Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis
US20080153894A1 (en) * 2002-12-19 2008-06-26 Pharmacia Corporation Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL26022A (en) * 1966-06-23 1971-06-23 Haber R Nitrofuryl quinoline derivatives

Also Published As

Publication number Publication date
IE43251B1 (en) 1981-01-14
DE2612250B2 (de) 1977-12-29
AU1546176A (en) 1978-01-05
ES449874A1 (es) 1977-08-16
NZ181336A (en) 1978-04-28
AT346119B (de) 1978-10-25
FI761885A ( ) 1977-01-04
ZA763747B (en) 1977-05-25
DK298576A (da) 1977-01-04
FR2315931A1 (fr) 1977-01-28
IL47633A (en) 1978-08-31
JPS527971A (en) 1977-01-21
CH601291A5 ( ) 1978-07-14
DE2612250A1 (de) 1977-01-13
DE2612250C3 (de) 1978-08-31
BE843642A (fr) 1976-12-30
IL47633A0 (en) 1975-10-15
ATA485476A (de) 1978-02-15
SE7607630L (sv) 1977-01-04
LU75285A1 ( ) 1977-02-23
NL7607231A (nl) 1977-01-05
FR2315931B1 ( ) 1979-05-18
IT1063791B (it) 1985-02-11
JPS6127371B2 ( ) 1986-06-25
AU510163B2 (en) 1980-06-12
IE43251L (en) 1977-01-03
US4070469A (en) 1978-01-24

Similar Documents

Publication Publication Date Title
IE41374B1 (en) A composition for treating schizophrenia
SE9301290D0 (sv) Anvaendning av en somatostatinanalog
ES460098A1 (es) Metodo para producir derivados de acido penicilanico.
ES8102141A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
GB1507643A (en) 4-(5-nitro-2-furyl)quinaldinic acid n-oxide and its use in the treatment of bovine mastitis
DE3474774D1 (en) Therapeutic compositions for oral use containing stable s-adenosy1-l-methionine salts
MY129946A (en) Compound with gastric acid inhibitory effect and process for its preparation.
GB1487334A (en) Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof
SE7601535L (sv) Injicerbara antibiotiska kompositioner
US3019167A (en) Method of administering streptokinase systemically
IE34609L (en) Therapeutic substituted thiazolidinedione
IE36780B1 (en) New pharmaceutical preparations
JPS5170769A (en) 10*111 jihidoro 33 karubokishishipuroheputajin oyobi sono nn okisaido
GB1180120A (en) Pharmaceutical Compositions Containing Alkaloids.
ES469840A1 (es) Procedimiento para la obtencion de nuevos derivados de tria-zolotiadiacinas.
GB1444558A (en) Pyridylthioureas
ES483463A1 (es) Procedimiento de preparacion de los esteres del 1-metil-4- piperidinol
GB1412891A (en) Sulphamoyl-quinazolinones
GB1437149A (en) Spiro-compounds and a process for their preparation
GB1477996A (en) Quinolizine derivatives and their preparation
GR3004272T3 ( )
GB1345319A (en) Pharmaceutically active thioalkylamine
GB1492180A (en) Pharmaceutical composition for the treatment of hyperammoniemia
GB1317099A (en) 3-sulphamyl-4-chlorobenzoic acid derivatives

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee